Executive Compensation Schedule for Named Officers of Myriad Genetics, Inc. (Fiscal 2005–2006)
Contract Categories:
Human Resources
›
Compensation Agreements
Summary
This document outlines the base salaries and bonuses for the named executive officers of Myriad Genetics, Inc. for fiscal years 2005 and 2006. It lists the compensation details for the President and CEO, as well as other key executives, specifying their annual base salaries and bonuses. One executive, Dr. Skolnick, is paid hourly, with his base salary shown as an annualized figure. The agreement sets forth the financial terms for these officers but does not include additional employment terms or conditions.
EX-10.1 2 a2159440zex-10_1.htm EX-10.1
QuickLinks -- Click here to rapidly navigate through this document
QuickLinks -- Click here to rapidly navigate through this document
EXHIBIT 10.1
COMPENSATION OF NAMED EXECUTIVE OFFICERS
| Name and Position | Fiscal 2005 Base Salary ($) | Fiscal 2006 Base Salary ($) | Fiscal 2005 Bonus ($) | |||
|---|---|---|---|---|---|---|
| Peter D. Meldrum President and Chief Executive Officer | 580,000 | 615,000 | 290,000 | |||
| Gregory C. Critchfield, M.D. President, Myriad Genetic Laboratories, Inc. | 400,000 | 424,000 | 170,000 | |||
| Adrian N. Hobden, Ph.D. President, Myriad Pharmaceuticals, Inc. | 400,000 | 424,000 | 170,000 | |||
| Jay M. Moyes Vice President of Finance, Chief Financial Officer | 308,000 | 326,500 | 100,000 | |||
| Mark H. Skolnick, Ph.D.(1) Chief Scientific Officer | 420,000 | 445,000 | 105,000 |
- (1)
- Dr. Skolnick is compensated on an hourly basis. Base salary information reflects an annualized salary based on 2080 hours worked in a fiscal year. Actual amounts paid to Dr. Skolnick may vary significantly depending on the actual number of hours worked.
QuickLinks
